found that CCR8 was differentially expressed by the entire tumor–resident Treg cell population, which indicated that targeting CCR8 may be a promising means by which to selectively deplete Tregs in the TME, although the role of CCR8 in Treg function remains unclear (78). Here, CCR8 is linked to neoplasm.